Timber Pharmaceuticals Inc (TMBR)


Stock Price Forecast

Nov. 29, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Timber Pharmaceuticals Inc chart...

About the Company

timber pharmaceuticals llc, a clinical-stage medical dermatology company, focuses on the development and commercialization of pharmaceuticals for treatment of orphan dermatologic diseases. the company was founded in 2019 and is based in woodcliff lake, new jersey.

Exchange

NYSE MKT LLC

Website

http://www.thompson-designs.com/

$0M

Total Revenue

7

Employees

$1M

Market Capitalization

-0.06

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $TMBR News

Timber Pharmaceuticals Announces Official Name Change

2mon ago, source: TipRanks on MSN

Timber Pharmaceuticals (TMBRQ) has released an update to notify the public and investors about corporate charter and bylaws ...

Timber Pharmaceuticals Inc (BPC.MU)

1y ago, source: Yahoo Finance

WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a clinical-stage biopharmaceutical ...

TMBRQ Trex Wind-down, Inc.

8d ago, source: Seeking Alpha

Timber Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company’s lead ...

TMBRQ Timber Pharmaceuticals, Inc.

1mon ago, source: Seeking Alpha

The security has traded for less than one year There is no Wall Street analyst coverage The security is a closed-end fund or a mortgage REIT The security is listed on a non-US exchange The ...

Vertex Pharmaceuticals Inc VRTX

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Actinium Pharmaceuticals Inc ATNM

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Allergic Reaction Focused ARS Pharmaceuticals' Lead Candidate Shows Efficacy In Skin Disorder

on MSN ago, source:

Monday, ARS Pharmaceuticals Inc (NASDAQ:SPRY) released efficacy results ... DIY Revenues, Online Struggles, Timber Troubles, ...

Collegium Pharmaceutical, Inc.

2mon ago, source: CNN

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

Madrigal Pharmaceuticals, Inc.

4mon ago, source: CNN

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead ...

Conifex Timber Inc (CFF)

1mon ago, source: Investing

On this page, you can find detailed information about the financial performance of Conifex Timber Inc, including the latest Conifex Timber Inc earnings report and upcoming earnings date. The page ...

Trex Wind Down Inc (TMBRQ)

10d ago, source: Investing

Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of ...

Timber Pharmaceuticals Inc (BPC.BE)

3mon ago, source: Yahoo Finance

Timber Pharmaceuticals, Inc. (TMBR) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...